|
PSMD11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.444700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.833500E-04 |
| Normal-vs-Stage2 |
5.890500E-02 |
| Normal-vs-Stage3 |
1.645010E-04 |
| Normal-vs-Stage4 |
1.233570E-04 |
| Stage1-vs-Stage2 |
3.644000E-01 |
| Stage1-vs-Stage3 |
5.554000E-01 |
| Stage1-vs-Stage4 |
3.126000E-01 |
| Stage2-vs-Stage3 |
2.128400E-01 |
| Stage2-vs-Stage4 |
1.285980E-01 |
| Stage3-vs-Stage4 |
5.786000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.610700E-04 |
| Normal-vs-AfricanAmerican |
1.407410E-01 |
| Normal-vs-Asian |
1.555180E-03 |
| Caucasian-vs-AfricanAmerican |
3.188800E-01 |
| Caucasian-vs-Asian |
6.161600E-01 |
| AfricanAmerican-vs-Asian |
2.176200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.162050E-04 |
| Normal-vs-Female |
4.190700E-04 |
| Male-vs-Female |
1.407590E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.056560E-03 |
| Normal-vs-Age(41-60Yrs) |
1.153220E-04 |
| Normal-vs-Age(61-80Yrs) |
3.324700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.369030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.113800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.751400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.453000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.797600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.009600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.571800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.124000E-01 |
| Classical-VS-Follicular |
2.449500E-02 |
| Classical-VS-Other |
5.530400E-02 |
| Classical-VS-Normal |
2.164200E-03 |
| Tall-VS-Follicular |
3.221600E-01 |
| Tall-VS-Other |
5.940300E-02 |
| Tall-VS-Normal |
7.439100E-03 |
| Follicular-VS-Other |
2.987000E-01 |
| Follicular-VS-Normal |
7.98650000000123E-05 |
| Other-VS-Normal |
1.583840E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.381370E-04 |
| Normal-vs-N1 |
1.616110E-04 |
| N0-vs-N1 |
3.612400E-01 |
|
|
